全文获取类型
收费全文 | 66014篇 |
免费 | 5037篇 |
国内免费 | 276篇 |
专业分类
耳鼻咽喉 | 813篇 |
儿科学 | 1848篇 |
妇产科学 | 1233篇 |
基础医学 | 8527篇 |
口腔科学 | 1056篇 |
临床医学 | 7132篇 |
内科学 | 14996篇 |
皮肤病学 | 1154篇 |
神经病学 | 6608篇 |
特种医学 | 2411篇 |
外国民族医学 | 2篇 |
外科学 | 10602篇 |
综合类 | 458篇 |
一般理论 | 47篇 |
预防医学 | 4780篇 |
眼科学 | 855篇 |
药学 | 3821篇 |
中国医学 | 109篇 |
肿瘤学 | 4875篇 |
出版年
2023年 | 314篇 |
2022年 | 616篇 |
2021年 | 1414篇 |
2020年 | 986篇 |
2019年 | 1693篇 |
2018年 | 1976篇 |
2017年 | 1499篇 |
2016年 | 1514篇 |
2015年 | 1853篇 |
2014年 | 2516篇 |
2013年 | 3442篇 |
2012年 | 4582篇 |
2011年 | 4968篇 |
2010年 | 2972篇 |
2009年 | 2786篇 |
2008年 | 4306篇 |
2007年 | 4518篇 |
2006年 | 4285篇 |
2005年 | 4255篇 |
2004年 | 3946篇 |
2003年 | 3835篇 |
2002年 | 3696篇 |
2001年 | 570篇 |
2000年 | 419篇 |
1999年 | 544篇 |
1998年 | 770篇 |
1997年 | 657篇 |
1996年 | 502篇 |
1995年 | 539篇 |
1994年 | 437篇 |
1993年 | 418篇 |
1992年 | 269篇 |
1991年 | 298篇 |
1990年 | 247篇 |
1989年 | 211篇 |
1988年 | 208篇 |
1987年 | 210篇 |
1986年 | 201篇 |
1985年 | 200篇 |
1984年 | 239篇 |
1983年 | 204篇 |
1982年 | 257篇 |
1981年 | 250篇 |
1980年 | 218篇 |
1979年 | 132篇 |
1978年 | 138篇 |
1977年 | 118篇 |
1976年 | 94篇 |
1975年 | 88篇 |
1972年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Marc Ziegler Alexandre Castro-Caldas Susanna Del Signore Olivier Rascol 《Movement disorders》2003,18(4):418-425
Piribedil is a non-ergot D2/D3 agonist with a significant antagonist action on alpha2A and alpha2C adrenergic receptor subtypes. This double-blind placebo-controlled study was undertaken to confirm the efficacy of 150 mg/day piribedil po in improving motor symptoms of idiopathic Parkinson's disease (PD) in nonfluctuating patients insufficiently controlled by a stable daily dose of levodopa (L-dopa). Efficacy was assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) III score as primary criterion over 4 months. A second comparison was planned at 6 months, after possible adjustment of L-dopa. At 4 months, the rate of response, defined as a 30% decrease from baseline on UPDRS III score, was significantly greater with piribedil compared with placebo (56.4% vs. 37.7%; P = 0.040). At 6 months, the better efficacy of piribedil was maintained (61.8% of responders vs. 39.6% on placebo; P = 0.020). The difference between groups on UPDRS III change from baseline reached statistical significance only at 6 months: -10.0 points in the piribedil group vs. -6.7 points in the placebo group (P = 0.037). Secondary end-points were not significantly different. The most frequently reported adverse events were gastrointestinal symptoms (27 of 61 patients in the piribedil group vs. 13 of 54 patients in the placebo group). In conclusion, a 6-month oral administration of 150 mg/day piribedil in combination with L-dopa is well tolerated, except for minor gastrointestinal symptoms at the beginning of the treatment and significantly improves motor symptoms compared with placebo in PD nonfluctuating patients. 相似文献
92.
Robert G. Frank Allyson E. Haut Megan Smick Marc W. Haut John M. Chaney 《Brain injury : [BI]》1990,4(3):289-295
Cognitive deficits associated with closed head injury (CHI) have been well studied. Less attention has been directed to the emotional consequences of CHI and subsequent attempts to cope with major life events. CHI typically constitutes a catastrophic injury, yet few studies have examined coping strategies used by individuals after CHI or the effects of CHI on family functioning that may mediate coping. Previous workers have speculated that time since injury is a crucial determinant of coping; however, this has not been investigated with regard to CHI. In this preliminary investigation, 40 patients with CHI were compared with 17 neurologically intact controls. The CHI group was divided into two groups according to time since injury. It was found that patients with CHI used information seeking as their most dominant coping strategy regardless of their time since injury. Patients with CHI had higher family cohesion scores than control subjects. Implications of these findings for psychological response to CHI are discussed. 相似文献
93.
M.D.Robert R. Bahnson M.D.B. Simon Slasky M.D.Marc S. Ernstoff M.D.Barbara F. Banner 《Urology》1990,35(6)
The ultrasonographic characteristics of an epidermoid cyst of the testicle are presented. Since these, findings are similar to other published case reports, preoperative sonographic diagnosis of this lagon may be possible. 相似文献
94.
Gunter Deppe M.D. Marc L. Kahn M.D. Vinay K. Malviya M.D. John M. Malone Jr. M.D. Carl W. Christensen M.D. Ph.D. 《Gynecologic oncology》1996,62(3):340-343
Experience with the P.A.S.-PORT, a peripherally implanted central venous access device, is evaluated in a retrospective review of 154 patients from July 1991 to June 1994. Blood could not be aspirated from six patients. Complications included temporary minor thrombophlebitis in seven patients (4.5%), symptomatic axillary or subclavian vein thrombosis in five patients (3.2%), clotted port in two patients (1.2%), port pocket cellulitis in two patients (1.2%), and fungal sepsis in two patients (1.2%). In six patients (3.8%) the P.A.S.-PORT had to be removed because of complications. The P.A.S.-PORT facilitated delivery of chemotherapy, parenteral nutrition, blood products, antibiotics, hydration, and blood sampling. It was demonstrated that the P.A.S.-PORT may be inserted and used with a low incidence of complications in gynecologic cancer patients. 相似文献
95.
Hsiu Hui Chiu Hsiao Hui Chou Wen Dar Jean Wung Yang Shieh 《Journal of microbiology, immunology, and infection》2007,40(1):14-23
BACKGROUND AND PURPOSE: Marine luminous bacteria were isolated and identified from samples in shallow coastal waters of Taiwan during the relatively warm seasons. METHODS: Identification of the luminous isolates was performed based on differences of phenotypic and genotypic characteristics together with data from phylogenetic analysis. RESULTS: Twenty seven strains of marine luminous bacteria were isolated. They were divided into five types based on differences of phenotypic characteristics. However, they could be clustered into only two genotypes according to the analysis of restriction patterns of polymerase chain reaction-amplified 16S rRNA genes digested with various restriction enzymes. The characterization data together with the 16S rRNA gene-based phylogenetic analysis revealed that the isolates included in phenotype I (seven isolates) could be Photobacterium leiognathi, and those included in phenotypes II-V (twenty isolates) might be classified as Vibrio harveyi. However, phylogeny based on gyrB sequences indicated that phenotypes II-V could be classified into two species, V. harveyi and Vibrio campbellii. CONCLUSION: Culturable luminous bacteria in the shallow coastal waters of Taiwan during the sampling period are dominated by V. harveyi/campbellii and P. leiognathi, and the former species appeared to be more prevalent and numerous than the latter species in general. 相似文献
96.
Christina Djokoto George Tomlinson Stephen Waldman Marc Grynpas Angela M. Cheung 《Journal of clinical densitometry》2004,7(4):448-456
Dual-energy X-ray absorptiometry (DXA) and quantitative ultrasound (QUS) are the accepted modalities for the evaluation of fracture risk in the clinical setting. However, neither method provides a direct measurement of bone mechanics. In this study, we investigated a prototype device, known as a mechanical response tissue analyzer (MRTA), which provides direct mechanical measurements of mechanical properties of bone. A total of 56 healthy volunteers (20 men and 36 women) between the ages of 18 and 83 were recruited. The MRTA was used to measure the cross-sectional bending stiffness (EI) of the ulna bone. Axial speed of sound (SOS) at the ulna bone was determined by QUS; bone mineral content (BMC) and bone mineral density (BMD) were determined by DXA. Correlations, regression analysis, and analyses of variance (ANOVAs) were used to compare the three modalities. These analyses revealed that although there are strong linear relationships among the data collected by the various technologies, the bone properties reflected by MRTA are not fully explained by DXA and QUS. We conclude that the total information conveyed by MRTA measurements is unique. Further research is needed to delineate the different qualities of bone strength that are captured by MRTA, but not by DXA or QUS. 相似文献
97.
98.
99.
100.
Devi Kanikanti Padmalatha Rao Kanikanti V. Ranga Baveja Srikrishan Fathi Marc Roth Marc 《Pharmaceutical research》1989,6(4):313-317
Zero-order release of oxprenolol hydrochloride was obtained by controlling the swelling and erosion of the matrix. This formulation involves only mixing of drug, hydroxypropylmethylcellulose (HPMC), and sodium carboxymethylcellulose (Na CMC) at the ratio of 1:0.4:1.6, respectively, and compressing the mixture directly into tablets. The in vitro release pattern from this optimized matrix tablet was reproducible. Accelerated stability studies revealed that the optimized formulation remains stable for an approximately 2-year shelf life. This sustained-release (SR) tablet was evaluated in dogs, and for comparison a conventional (CV) formulation was also given at the same dose level. Plasma oxprenolol levels were monitored by a sensitive and specific high-performance liquid chromatographic (HPLC) method. Significant differences in the pharmacokinetic parameters, i.e., lower C
max, higher values of t
max, MRT, AUC, and plasma concentration at 24 hr, and nearly constant plasma levels over 12 hr, indicated that the SR matrix tablet is superior to the CV rapid-releasing formulation. The in vitro release parameters and in vivo pharmacokinetics correlated well. 相似文献